What do the recent FDA approvals in the DTx space mean for the industry?
Snapshot Better Therapeutics’ de Novo announcement emphasizes its product’s mechanism of action and high patient engagement. MedRhythms adopts…
Day: August 23, 2023
4 posts
Cellares Secures $255M Series C Funding to Revolutionize Cell Therapy Manufacturing
Cellares, a pioneering force in cell therapy manufacturing, has announced a successful $255 million Series C funding round.…
#386 – Dedi Gilad CEO and Co-Founder at TytoCare
Episode Details Join us on the latest episode! Our Guest: Dedi Gilad CEO And Co-Founder At TytoCare What…
#14 – Simon Arkell, CEO and Co-Founder of Synthetica Bio
In this episode we discuss: Join the Bio Breakthroughs podcast host, Jared S Taylor, as he welcomes Simon…